ALBUTROPIN Trademark

Trademark Overview

On Friday, July 9, 2004, a trademark application was filed for ALBUTROPIN with the United States Patent and Trademark Office. The USPTO has given the ALBUTROPIN trademark a serial number of 78448230. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 2, 2009. This trademark is owned by Human Genome Sciences, Inc.. The ALBUTROPIN trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, fusion protein for treatment of growth hormone deficiency
albutropin

General Information

Serial Number78448230
Word MarkALBUTROPIN
Filing DateFriday, July 9, 2004
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, March 2, 2009
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 8, 2005

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, fusion protein for treatment of growth hormone deficiency

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, July 19, 2004
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHuman Genome Sciences, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressRockville, MD 20850
Party NameHuman Genome Sciences, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressRockville, MD 20850

Trademark Events

Event DateEvent Description
Monday, March 2, 2009ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, March 2, 2009ABANDONMENT - NO USE STATEMENT FILED
Thursday, July 24, 2008EXTENSION 5 GRANTED
Thursday, July 24, 2008EXTENSION 5 FILED
Thursday, July 24, 2008TEAS EXTENSION RECEIVED
Thursday, January 31, 2008EXTENSION 4 GRANTED
Thursday, January 31, 2008EXTENSION 4 FILED
Thursday, January 31, 2008TEAS EXTENSION RECEIVED
Tuesday, July 31, 2007EXTENSION 3 GRANTED
Tuesday, July 31, 2007EXTENSION 3 FILED
Tuesday, July 31, 2007TEAS EXTENSION RECEIVED
Thursday, December 21, 2006EXTENSION 2 GRANTED
Thursday, December 21, 2006EXTENSION 2 FILED
Thursday, December 21, 2006TEAS EXTENSION RECEIVED
Friday, October 6, 2006ASSIGNED TO EXAMINER
Tuesday, August 29, 2006EXTENSION 1 GRANTED
Friday, July 28, 2006EXTENSION 1 FILED
Friday, July 28, 2006TEAS EXTENSION RECEIVED
Tuesday, January 31, 2006NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 8, 2005PUBLISHED FOR OPPOSITION
Wednesday, October 19, 2005NOTICE OF PUBLICATION
Tuesday, August 30, 2005LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, August 26, 2005ASSIGNED TO LIE
Thursday, August 25, 2005APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 18, 2005AMENDMENT FROM APPLICANT ENTERED
Friday, August 12, 2005CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, August 12, 2005TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, February 14, 2005NON-FINAL ACTION E-MAILED
Monday, February 14, 2005NON-FINAL ACTION WRITTEN
Monday, February 14, 2005ASSIGNED TO EXAMINER
Tuesday, January 11, 2005TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, July 19, 2004NEW APPLICATION ENTERED IN TRAM

Related Keywords

albutropin growth hormone deficiency treatment protein preparations namely fusion pharmaceutical